Douglas Adkins, Robert I. Haddad, Yungan Tao, Christophe Le Tourneau, Nancy Y. Lee, Kunal Sindhu, Rebecca Chernock, Makoto Tahara, Kevin Joseph Harrington, Arkadiy Klochikhin, Irene BraƱa, Gustavo Vasconcelos Alves, Brett Gordon Maxwell Hughes, Marc Oliva, Iane Pinto Figueiredo Lima, Tsutomu Ueda, Cole Manschot, Kimberly Thomas Benjamin, Behzad Bidadi, Ravindra Uppaluri. "Neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) in resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC): Exploratory efficacy analyses of the phase 3 KEYNOTE-689 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6012